Skip to main content
. 2021 Nov 17;37(9):1165–1173. doi: 10.1177/08850666211054369

Table 1.

Baseline and ICU Admission Characteristics.

Hematological malignancy (n = 10,401) Solid malignancy (n = 35,920) Without malignancy (n = 423,984)
Age (years) 63.9 (13.9) 67.5 (12.0) 62.3 (17.3)
Gender (male) 6495 (62.5%) 20,805 (57.9%) 238,323 (56.2%)
BMI 25.2 (4.8) 25.8 (5.1) 26.4 (5.9)
APACHE IV score 86 [68-109] 59 [43-81] 57 [38-81]
Comorbidity
 COPD and respiratory insufficiency 1405 (13.9%) 5687 (15.8%) 75,214 (17.7%)
 Renal insufficiency and dialysis 858 (8.2%) 1651 (4.6%) 27,699 (6.5%)
 Liver cirrhosis 110 (1.1%) 337 (0.9%) 7806 (1.8%)
 Cardiovascular insufficiency 328 (3.2%) 1050 (2.9%) 21,645 (5.1%)
 Immunological insufficiency 6210 (59.7%) 6121 (17.0%) 23,621 (5.6%)
Underlying type hematological malignancy
 Leukemia 1342 (12.9%)
 Hodgkin lymphoma 118 (1.1%)
 Non-Hodgkin lymphoma 813 (7.8%)
 Bone marrow transplant 57 (0.5%)
 Hematological malignancy, not specified 8071 (77.6%)
Specification cohort 1
 Comorbidity: hematological malignancy 6599 (63.4%)
 Referral specialism: hematology 284 (2.7%)
 Both comorbidity and referral specialism 802 (7.7%)
 APACHE IV diagnosis: hematological malignancy 2330 (22.4%)
 APACHE IV diagnosis: other 386 (3.7%)
Underlying type solid malignancy
 Gastrointestinal malignancy 11,037 (30.7%)
 Pancreas malignancy 842 (2.3%)
 Renal/urogenital malignancy 2985 (8.3%)
 Neurological malignancy 2144 (6.0%)
 Respiratory malignancy 4696 (13.1%)
 Solid malignancy, not specified 14,216 (39.6%)
Specification cohort 2
 Comorbidity: neoplasm 13,211 (36.8%)
 Referral specialism: oncology 183 (0.5%)
 Both comorbidity and referral specialism 344 (1.0%)
 APACHE IV diagnosis: solid malignancy 21,704 (60.4%)
 APACHE IV diagnosis: other 478 (1.3%)
Admission reason
 Respiratory failure 1038 (10.5%) 2062 (9.8%) 33,287 (7.9%)
 Sepsis 2454 (24.9%) 3484 (16.6%) 38,235 (9.0%)
 Pneumonia 2427 (24.6%) 2323 (11.0%) 40,097 (9.5%)
 Acute kidney injury/failure 163 (1.7%) 313 (1.5%) 4408 (1.0%)
 Complications of surgery 49 (0.5%) 730 (3.5%) 7375 (1.7%)
 Cardiac disease 582 (5.9%) 1289 (6.1%) 36,370 (8.6%)
 Cardiac arrest 351 (3.6%) 849 (4.0%) 27,074 (6.4%)
 Neurological 465 (4.7%) 1213 (5.8%) 38,350 (9.0%)
 Medication related 17 (0.2%) 81 (0.4%) 15,493 (3.7%)
 Gastrointestinal 885 (9.0%) 4388 (20.9%) 47,987 (11.3%)
 Metabolic/endocrine 176 (1.8%) 578 (2.7%) 11,362 (2.8%)
 Thromboembolism 146 (1.5%) 612 (2.9%) 11,548 (2.7%)
 Other 1111 (11.3%) 3078 (14.6%) 111,798 (26.4%)
Admission type
 Medical 9212 (88.7%) 13,540 (38.0%) 296997 (71.4%)
 Emergency surgery 888 (8.6%) 7435 (20.9%) 81295 (19.5%)
 Elective surgery 280 (2.7%) 14,624 (41.1%) 37707 (9.1%)
Admitted from
 Emergency department 2243 (21.9%) 4286 (12.1%) 150,865 (36.6%)
 Operation theatre 1019 (10.0%) 19,353 (54.5%) 101,675 (24.6%)
 Ward 6101 (59.6%) 10,203 (28.7%) 122,253 (29.6%)
 CCU/ICU 678 (6.6%) 950 (2.7%) 25,342 (6.1%)
 Special/medium care 64 (0.6%) 299 (0.8%) 2748 (0.7%)
 Home 78 (0.8%) 191 (0.5%) 5469 (1.3%)
 Other 49 (0.5%) 231 (0.7%) 4409 (1.1%)
Diagnoses at admission
 CPR 476 (4.6%) 1130 (3.1%) 30,616 (7.2%)
 Gastrointestinal bleeding 365 (3.5%) 1105 (3.1%) 12,960 (3.1%)
 Cardiovascular 1461 (14.1%) 3290 (9.2%) 57,336 (13.5%)
 Neurological 368 (3.5%) 1950 (5.4%) 12,960 (3.1%)
 Diabetes 1318 (12.7%) 5103 (14.2%) 68,826 (16.2%)
Diagnoses within 24 h of ICU admission
 Acute renal failure 2155 (20.7%) 3663 (10.2%) 47,142 (11.1%)
 Mechanical ventilation 5236 (50.3%) 13,105 (36.5%) 19,2411 (45.4%)
 Confirmed infection 4116 (39.6%) 6639 (18.5%) 83,919 (19.8%)
 Vasoactive drugs 4913 (47.2%) 13,186 (36.7%) 146,767 (34.6%)

Data are displayed as mean (standard deviation) for continuous and count (percentages) for categorical variables, all P values was highly significant with a P < 0.01.

Abbreviations: APACHE, Acute Physiology and Chronic Health Evaluation; BMI, body mass index; CCU, coronary care unit; CPR, cardiopulmonary resuscitation; COPD, chronic obstructive pulmonary disorder; ICU, intensive care unit.